R
Renovaro Biosciences Inc
F:2Q5
Renovaro Biosciences Inc
F:2Q5
Price:
0.1028
EUR
Market Closed
Market Cap:
€15.8m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Renovaro Biosciences Inc
F:2Q5
|
US |
|
P
|
Planisware SA
PAR:PLNW
|
FR |
|
M
|
Mercury NZ Ltd
SWB:MRY
|
NZ |
|
J
|
Jasa Marga (Persero) Tbk PT
XBER:0JM
|
ID |
|
N
|
National Retail Properties Inc
F:CZ2
|
US |
|
Y
|
Yandex NV
MOEX:YNDX
|
NL |
|
N
|
Nine Entertainment Co Holdings Ltd
F:NEE
|
AU |
|
T
|
Technogym SpA
F:TN2
|
IT |
|
K
|
Kaiser Aluminum Corp
SWB:KLU1
|
US |
|
P
|
PSP Projects Ltd
BSE:540544
|
IN |
|
S
|
SATS Ltd
SWB:W1J
|
SG |
|
Vision Inc
TSE:9416
|
JP |
|
Lithium Argentina AG
NYSE:LAR
|
CH |
|
P
|
Panasonic Manufacturing Malaysia Bhd
KLSE:PANAMY
|
MY |
|
RPMGlobal Holdings Ltd
ASX:RUL
|
AU |
|
Ubisoft Entertainment SA
XETRA:UEN
|
FR |
|
I
|
Insperity Inc
SWB:ASF
|
US |
|
C
|
China Reinsurance Group Corp
SWB:C53
|
CN |
Multiples-Based Value
There is not enough data to reliably calculate the multiples-based value of 2Q5.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
2Q5
Multiples-Based Value
Not Available
